Baskın Veysel, Bilge S Sırrı, Bozkurt Ayhan, Akyüz Bahar, Ağrı Arzu Erdal, Güzel Hasan, İlkaya Fatih
Department of Pharmacology, Medical Faculty, University of Ondokuz Mayis, Samsun, Turkey.
Department of Physiology, Medical Faculty, University of Ondokuz Mayis, Samsun, Turkey.
Indian J Pharmacol. 2016 Mar-Apr;48(2):150-4. doi: 10.4103/0253-7613.178830.
To investigate nonsteroidal anti-inflammatory drugs effectiveness in colorectal distension (CRD)-induced visceral pain model.
Male Sprague-Dawley (250-300 g) rats were anesthetized with ketamine (50 mg/kg, intraperitoneally [i.p.]) and chlorpromazine (25 mg/kg, i.p.). Two bipolar Teflon-coated Ni/Cr wire electrodes (80-M diameter) were placed in the abdominal external oblique muscle for the recording of electromyography. Jugular vein catheter was placed for the administration of drugs. CRD method was applied to evaluate of visceral pain. All drugs (paracetamol, meloxicam, metamizole, and dexketoprofen) administered intravenously.
Paracetamol 200, 400, and 600 mg/kg did not change the visceromotor response (VMR) when compare with the control group. Meloxicam 2 and 4 mg/kg showed no effect but at doses of 6 mg/kg meloxicam significantly ([51.9 ± 6.4%] [P < 0.001]) decreased VMR compared with the control group. Metamizole 200 mg/kg did not change responses but dose of 400 and 600 mg/kg metamizole reduced VMR. Dexketoprofen 2 and 4 mg/kg did not cause a change in VMR but 6 mg/kg dose significantly reduced response compared with the control group ([43.9 ± 3.9%, 36.8 ± 2.8%, 34.8 ± 2.5%, 42.1 ± 4.8%, 40.7 ± 3.5%, 36.4 ± 2.7%, and 26.1 ± 2.2%]; from 10 min to 70 min, respectively, [P < 0.05]).
Metamizole, dexketoprofen and meloxicam show antinociceptive effect with different duration of action on CRD-induced visceral pain model. This condition can be explained due to different chemical structures and different mechanisms which play a role in modulation of pain.
研究非甾体抗炎药在结直肠扩张(CRD)诱导的内脏痛模型中的有效性。
雄性Sprague-Dawley大鼠(250 - 300 g)用氯胺酮(50 mg/kg,腹腔注射[i.p.])和氯丙嗪(25 mg/kg,腹腔注射)麻醉。将两根双极聚四氟乙烯涂层的镍/铬丝电极(直径80 - M)置于腹外斜肌用于记录肌电图。放置颈静脉导管用于给药。采用CRD方法评估内脏痛。所有药物(对乙酰氨基酚、美洛昔康、安乃近和右酮洛芬)均静脉给药。
与对照组相比,200、400和600 mg/kg的对乙酰氨基酚未改变内脏运动反应(VMR)。2和4 mg/kg的美洛昔康无作用,但6 mg/kg剂量的美洛昔康与对照组相比显著降低了VMR([51.9 ± 6.4%] [P < 0.001])。200 mg/kg的安乃近未改变反应,但400和600 mg/kg剂量的安乃近降低了VMR。2和4 mg/kg的右酮洛芬未引起VMR变化,但与对照组相比,6 mg/kg剂量显著降低了反应([43.9 ± 3.9%,36.8 ± 2.8%,34.8 ± 2.5%,42.1 ± 4.8%,40.7 ± 3.5%,36.4 ± 2.7%,和26.1 ± 2.2%];分别从10分钟到70分钟,[P < 0.05])。
安乃近、右酮洛芬和美洛昔康对CRD诱导的内脏痛模型显示出不同作用持续时间的镇痛效果。这种情况可以用不同的化学结构和在疼痛调节中起作用不同的机制来解释。